New drugs recast $10 bln haemophilia market as Sanofi swoops in
January 22, 2018 at 07:21 AM EST
LONDON, Jan 22 (Reuters) - Sanofi is placing a big bet on the $10 billion-a-year haemophilia market at a testing time, as scientific advances overhaul traditional approaches to treating the rare uncontrolled bleeding disorder.
